Concordia Healthcare Corp. T.CXR.R

U.S.senate panel probing Valeant,Turing-drug costs Reduction

[healthstock1234]

maybe after that, we will see all sector green
https://www.reuters.com/article/2015/11/04/us-usa-congress-drugprices-idUSKCN0ST1S220151104#6pdAIyFlLsV4TKFO.97

[humbledude]

Don't worry about it, CXR Mark Thompson said in his last friday interview that CXR 's drug price is still significantly lower than its peer.   According to CXR 2016 guidance, CXR 2016 US sales will be total 30-40% of CXR, of which 90% is from general public sector, and only 10% from government reimbursement. That translates less then 5% of their revenue will be affect by the US

[healthstock1234]

Yes, you are right for CXR. Just I hope that all these investigations about drug price will finish as quickly as possible. Valeant has a high ability to integrate new business at once, but, it can take years to realize cost saving associated with this grow by acquisitions. I hope this will be the only explanation for Valeant and all the sector will be high again.